On 2024-05-10, iTeos Therapeutics, Inc. (ITOS) announced earnings per share of $-1.07 for the fiscal quarter ending 2024-03-31, missing the average analyst estimate of $-1.02.
The next expected annoucement date for quarterly earnings is 2024-08-13, with an average estimated earnings per share of $-1.04 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-10 | 2024-03-31 | $-1.02 | $-1.07 |
| 2024-03-06 | 2023-12-31 | $-1.03 | $-0.85 |
| 2023-11-07 | 2023-09-30 | $-1.20 | $-0.90 |
| 2023-08-08 | 2023-06-30 | $-1.03 | $-0.96 |
| 2023-05-10 | 2023-03-31 | $-0.99 | $-0.44 |
| 2023-03-15 | 2022-12-31 | $0.42 | $0.57 |
| 2022-11-10 | 2022-09-30 | $0.07 | $0.03 |
| 2022-08-10 | 2022-06-30 | $1.20 | $0.15 |
| 2022-05-12 | 2022-03-31 | $0.80 | $1.82 |
| 2022-03-23 | 2021-12-31 | $1.29 | $4.88 |
| 2021-11-10 | 2021-09-30 | $4.95 | $1.86 |
| 2021-08-12 | 2021-06-30 | $-0.41 | $-0.75 |
| 2021-05-13 | 2021-03-31 | $-0.48 | $-0.39 |
| 2021-03-24 | 2020-12-31 | -- | $-0.43 |
| 2020-11-12 | 2020-09-30 | $-0.37 | $-0.48 |